Volume Alert - SAN 8.26 Banco Santander $SAN Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - SAN 8.26 Banco Santander $SAN Hit a high today of 8.28 Closing the day 10:30 at 8.26 -0.14 -1.67% With a day low of 8.22 and a total volume of 1,374,508.

SAN Recent Posts: http://investorshangout.com/Banco-Santander-S...SAN-52719/

SAN Banco Santander Recent Headline News

Market Maker Surveillance Report. GILD, QCOM, SAN, MNKD, HST, BABA, Bullishly Biased Price Friction For Monday, November 10th 2014
M2 - Tue Nov 11, 2:31AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Monday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Monday there were 4913 companies with "abnormal" market making, 2783 companies with positive Friction Factors and 2128 companies with negative Friction Factors. Here is a list of the top companies with Abnormal Price Friction (bullish bias) in their stock prices. This means that there was more selling than buying in the stocks and their stock prices rose. GILEAD SCIENCES, INC. (NASDAQ:GILD), Qualcomm Inc (NASDAQ:QCOM), Banco Santander SA (NYSE:SAN), Mannkind Corp (NASDAQ:MNKD), Host Hotels and Resorts Inc (NYSE:HST), (NYSE:BABA). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
SAN: 8.23 (-0.17), HST: 22.78 (+0.02), GILD: 107.11 (-0.90), QCOM: 70.21 (+0.57), MNKD: 6.09 (+0.05), BABA: 118.40 (+3.86)

Regeneron and Sanofi Announce Positive Results from Phase 2b Study of Dupilumab in Patients with Moderate-to-Severe Asthma
PR Newswire - Tue Nov 11, 12:00AM CST
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (EURONEXT: SAN and NYSE: SNY) today announced positive results from the interim analysis of a dose-ranging Phase 2b study of dupilumab in adult patients with uncontrolled moderate-to-severe asthma. Dupilumab is an investigational therapy blocking IL-4 and IL-13, two cytokines required for the Th2 immune response.
SAN: 8.23 (-0.17), SNY: 46.28 (-0.86), REGN: 400.30 (+1.94)

Shares of SAN Down 12.4% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Mon Nov 10, 9:52AM CST
SmarTrend identified a Downtrend for Banco Santander (NYSE:SAN) on September 29th, 2014 at $9.47. In approximately 1 month, Banco Santander has returned 12.45% as of today's recent price of $8.29.
SAN: 8.23 (-0.17)

Promises, Promises; Markets Move on Draghi: Best of Kass
at The Street - Sun Nov 09, 4:05PM CST
In highlights from his trading diary of the past week, Doug Kass says the European Central Bank is jolting the markets and Monitise is looking more shaky.
KO: 42.81 (+0.30), SAN: 8.23 (-0.17), DVN: 64.24 (-0.32), XLP: 47.88 (+0.02), V: 251.43 (+1.70), SPY: 204.01 (-0.17), IBM: 162.26 (-1.04), FB: 74.16 (-0.45), XOM: 95.77 (-0.64), PG: 89.64 (-0.03), TWTR: 41.65 (+2.06), CVX: 118.11 (-0.33)

Providence drops suit vs. Santander over lending
By JENNIFER McDERMOTT - AP - Fri Nov 07, 12:42PM CST
PROVIDENCE, R.I. (AP) — Santander Bank has agreed to give $1.3 million in grants to support low- and moderate-income neighborhoods in Providence to resolve a lawsuit filed by the city.
SAN: 8.23 (-0.17), SANW: 3.51 (unch)

GE Capital closes sale of GE Money Bank
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 8:13AM CST

SAN: 8.23 (-0.17), GE: 26.56 (+0.18)

Update: Banco Santander Earnings
The Investment Doctor - at Seeking Alpha - Wed Nov 05, 9:45AM CST

SAN: 8.23 (-0.17)

Genzyme Announces Enrollment of First Patient in Phase II Vatelizumab Trial in Relapsing Remitting Multiple Sclerosis
Business Wire - Tue Nov 04, 5:00AM CST
Genzyme, a Sanofi company, announced today enrollment of the first patient in a multicenter Phase II clinical trial to evaluate Genzyme's investigational infusion therapy vatelizumab in patients with relapsing remitting multiple sclerosis (RRMS). The trial, called EMPIRE, is designed to assess the efficacy of vatelizumab vs. placebo in RRMS patients. The safety, tolerability and pharmacokinetics of vatelizumab will also be assessed.
SAN: 8.23 (-0.17), SNY: 46.28 (-0.86)

Santander Brasil slides continues as Banco Santander boosts stake
Seeking Alpha - at Seeking Alpha - Mon Nov 03, 10:34AM CST

SAN: 8.23 (-0.17), BSBR: 5.57 (+0.06)

Banco Santander Brasil (BSBR) Stock Continues to Sink After Share Buyout
at The Street - Mon Nov 03, 10:03AM CST
Banco Santander Brasil (BSBR) stock continues to tumble after its parent company raised its stake in the Brazilian unit to 88.3% last Friday.
SAN: 8.23 (-0.17), BSBR: 5.57 (+0.06)

Sanofi Pasteur Announces FDA Approval of Updated Prescribing Information for Fluzone® High-Dose Vaccine for Adults 65 and Older
PR Newswire - Mon Nov 03, 7:30AM CST
Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for Fluzone® High-Dose (Influenza Vaccine) to include efficacy data in the Prescribing Information. These data demonstrate that Fluzone High-Dose vaccine provided improved protection against influenza ("the flu" compared to standard-dose Fluzone vaccine (trivalent intramuscular formulation) in adults 65 years of age and older.
SAN: 8.23 (-0.17), SNY: 46.28 (-0.86)

Conference Participation, Dividend, Upcoming Annual Meeting, Training Program, and Promotional Event - Research Reports on Santander Brasil, Goldman Sachs, Visa, Banco Santander and American Express
PR Newswire - Thu Oct 30, 7:30AM CDT
Today, Analysts Review released its research reports regarding Banco Santander Brasil SA (NYSE: BSBR), The Goldman Sachs Group Inc. (NYSE: GS), Visa Inc. (NYSE: V), Banco Santander, S.A. (NYSE: SAN) and American Express Company (NYSE: AXP). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7556-100free.
SAN: 8.23 (-0.17), V: 251.43 (+1.70), GS: 189.98 (-1.90), AXP: 91.40 (-0.34), BSBR: 5.57 (+0.06)

Sanofi: Sanofi Delivers Business EPS Growth of 10.3% at CER
PR Newswire - Tue Oct 28, 7:34AM CDT
Sanofi (NYSE: SNY; EURONEXT: SAN)
SAN: 8.23 (-0.17), SNY: 46.28 (-0.86)

New International GPCR Consortium Formed with Pharma and Academia to Advance Structural Information about G-protein Coupled Receptors
PR Newswire - Tue Oct 28, 5:00AM CDT
The generation of high-resolution pictures of hundreds of medically important proteins known as G-protein coupled receptors (GPCRs) will be the goal of an ambitious new international partnership. Called the GPCR Consortium, this non-profit initiative brings together major pharmaceutical companies and leading research institutes from three continents to advance GPCR research for drug development. The human body is controlled by 826 GPCRs, which are involved in a wide variety of human physiology and are implicated in many diseases. As a drug target, GPCRs are highly valuable but mechanistically poorly understood and with limited structural information that could greatly aid in finding new drug candidates.
SAN: 8.23 (-0.17), SNY: 46.28 (-0.86)

Sanofi Q3 2014 Results - Interview with Jérôme Contamine
PR Newswire - Tue Oct 28, 2:00AM CDT
Sanofi, a global and diversified healthcare leader, reports results for the third-quarter of 2014. Jérôme Contamine, Chief Financial Officer of Sanofi, comments on results and full year guidance.
SAN: 8.23 (-0.17), SNY: 46.28 (-0.86)

SmarTrend Watching for Potential Rebound in Shares of Banco Santander After 2.58% Loss
Comtex SmarTrend(R) - Mon Oct 27, 4:08PM CDT
Banco Santander (NYSE:SAN) traded in a range yesterday that spanned from a low of $8.51 to a high of $8.72. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $8.67 on volume of 38.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
SAN: 8.23 (-0.17)

Skeptical markets hit sell button on EU lenders
Seeking Alpha - at Seeking Alpha - Mon Oct 27, 11:52AM CDT

EWI: 14.02 (-0.41), SAN: 8.23 (-0.17), EUFN: 22.42 (-0.38), ING: 13.74 (-0.30), DB: 29.54 (-0.61), BBVA: 10.53 (-0.26)

80% ECB Banks Pass Stress Test - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 9:55AM CDT
European banks emerged as healthier. Of 123 banks that were part of the stress test, only 24 failed to meet the minimum common equity ratio (CET1) level of 5.5%.
BCS: 14.52 (-0.40), SAN: 8.23 (-0.17), HSBC: 50.17 (-0.40), DB: 29.54 (-0.61), NBG: 2.07 (-0.13), RBS: 11.80 (-0.24), LYG: 4.77 (-0.07)

Review on Diversified Banks Stocks - US Bancorp, Banco Santander Brasil, Banco Santander, National Bank of Greece, and Comerica
PR Newswire - Fri Oct 24, 8:10AM CDT
Investor-Edge has initiated coverage on the following equities: US Bancorp (NYSE: USB), Banco Santander Brasil S.A. (NYSE: BSBR), Banco Santander S.A. (NYSE: SAN), National Bank of Greece S.A. (NYSE: NBG), and Comerica Inc. (NYSE: CMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, October 23, 2014, ended on a positive note as the Dow Jones Industrial Average finished at 16,677.90, up 1.32% and the NASDAQ Composite closed at 4,452.79, up 1.60%. The S&P 500 finished the session 1.23% higher at 1,950.82. During the trading session, eight out of ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day at 308.34, up 0.98%, with the index advancing 4.62% on YTD basis. Register for your complimentary reports on these five stocks at:
SAN: 8.23 (-0.17), USB: 43.86 (-0.17), NBG: 2.07 (-0.13), CMA: 48.83 (+0.31), BSBR: 5.57 (+0.06)

Wall Street Breakfast: Amazon Punished After Massive Loss
Wall Street Breakfast - Seeking Alpha - Fri Oct 24, 5:31AM CDT
Economy A NYC doctor, who returned to New York ten days ago after treating Ebola patients in West Africa, has tested positive for the virus. Late in the trading session yesterday, stocks gave back some of their big gains on a report he had been...
SD: 3.88 (+0.10), TSLA: 248.20 (-2.88), AMZN: 311.89 (-0.12), LMT: 187.05 (-0.07), AMCX: 61.36 (-0.03), C: 53.36 (-0.45), ELNK: 4.34 (-0.04), HSBC: 50.17 (-0.40), TM: 118.46 (-0.68), RBS: 11.80 (-0.24), SAN: 8.23 (-0.17), SPY: 204.01 (-0.17), QQQ: 102.40 (+0.12), GM: 31.18 (-0.17), MSFT: 48.87 (unch), HMC: 31.22 (+0.21)

Banco Santander S.A. (SAN) Stock Research Links

SAN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lake Ridge's Strong Quarter Meets a Book Value Hit

Updated Category News Views 105

An $8.25-per-share securities markdown is the splinter in an otherwise sturdy third-quarter report from Lake Ridge Bancorp. The bank earned $9.8 million, or $4.97 per common share, for the quarter ended September 30, 2026. That is up from $9.0 million, or $4.59 per share, in the prior quarter and $7.7 million, or $3.94 per share, a year earlier. Those are not flimsy...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Perform.AI Tests Whether Stores Can Sell to Agents

Updated Category News Views 34

Shopping bots are about to become one more fussy customer standing in the aisle, except this one reads machine-facing files, rejects broken checkout steps, and does not care how pretty the homepage looks. Perform.AI has launched a free UCP and ACP Readiness Checker aimed at online retailers that need to know whether AI agents can find products, purchase them, and follow...

Continue Reading
MobileX's $10 Plan Puts Holiday Pressure on Wireless

Updated Category News Views 157

A sixty-dollar commitment is a small bet, but in wireless it can become a loud little nuisance for every carrier charging far more. MobileX has rolled out a Black Friday offer giving new customers 10GB of high-speed data, unlimited talk and text, and six months of service for $60 upfront. That pencils out to $10 a month, before taxes and government surcharges, and it runs...

Continue Reading
Google Search Data Sharing Faces a Privacy Reality Check

Updated Category News Views 58

Search queries are messy little confessions, and that is exactly why this case deserves more than a bureaucratic shrug. Woodway Assurance's independent assessment says Google's search-query data could be treated as anonymized for sharing under the Digital Markets Act, but only if the European Commission tightens parts of its July 2026 framework. That is not a clean bill...

Continue Reading
Hexaware’s Seven-Year Client Signal Is Worth Watching

Updated Category News Views 112

Seven straight years of recognition is harder to shrug off than one shiny plaque on a corporate shelf. Hexaware Technologies announced on November 18, 2026 that it received the ISG Star of Excellence Award in the Client Champion category, marking its seventh consecutive year of recognition in that awards program. For investors following IT services, that is a...

Continue Reading
RCA Mount Dora Widens Addiction Care Insurance Reach

Updated Category News Views 140

Insurance paperwork rarely looks heroic, yet it can decide whether treatment starts before a crisis gets worse. Recovery Centers of America at Mount Dora has added Aetna and Cigna/Evernorth to its in-network roster for every level of substance use disorder care, a practical move with real consequences for patients and families across Central Florida. Coverage matters most...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 130

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
ASUS Brings AI Infrastructure Choices to SC26 Floor

Updated Category News Views 257

Compute buyers are sick of being handed one locked box That is the nerve ASUS is pressing at SC26: enterprises want AI infrastructure that fits the job in front of them, not somebody else's tidy product roadmap. The company is pitching a full-stack “AI Factory” blueprint built across Intel, AMD and NVIDIA hardware, running from rack-scale systems and conventional...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 79

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading

Top 5 Most Recently Viewed Articles

Shell plc Announces Strategic Share Buybacks Amid Market Moves

Updated Category News Views 250

Shell plc Engages in Significant Share Buybacks Transaction in Own Shares Shell plc, a global leader in energy and petrochemical sectors, has undertaken a strategic initiative involving the purchase of its own shares for cancellation to optimize its capital structure. This decision aligns with the company’s broader strategy to enhance shareholder value through various...

Continue Reading
CSL Seqirus Strengthens Pandemic Readiness with New BARDA Award

Updated Category News Views 280

CSL Seqirus Receives Significant BARDA Award CSL Seqirus has recently received a noteworthy award from the Biomedical Advanced Research and Development Authority (BARDA). This grant is aimed at furthering the company's capabilities in preparing for potential pandemic situations through the development of avian influenza vaccines. The need for preparedness in public health...

Continue Reading
Navient’s Third Quarter Results: Financial Performance Insights

Updated Category News Views 86

Navient Announces Third Quarter 2024 Financial Results HERNDON, Va. — Navient (Nasdaq: NAVI) shared its third quarter financial results for 2024, showcasing the company’s ongoing commitment to providing innovative financial services and solutions. The comprehensive financial results are listed on the company's official site, ensuring transparency and accessibility for...

Continue Reading
Comstock Inc. Unveils Insights from 3Q24 Stakeholder Analysis

Updated Category News Views 169

Comstock Inc. (NYSE: LODE) dropped its Q3 2024 Stakeholder Perception Analysis Report, and you know how these things go—traders squinted at the numbers while trying to decipher what the hell it meant for their investments. So here's the deal: Comstock put out this report to show how its stakeholders felt about its performance and strategy, but really, it raised more...

Continue Reading
GraniteShares Unveils Innovative YieldBOOST Fund-of-Funds ETFs

Updated Category News Views 370

GraniteShares Introduces Unique Fund-of-Funds ETFs GraniteShares, an innovative leader in the ETF space, has recently introduced two new YieldBOOST Fund-of-Funds ETFs. These expansions reflect their commitment to offering cutting-edge investment solutions that cater to the evolving needs of investors. What Are the New ETFs? The two new offerings are the GraniteShares...

Continue Reading